High Resolution Nanoscale Probing of Bacteriophages in an Inhalable Dry Powder Formulation for Pulmonary Infections
- 20 September 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 91 (20) , 12760-12767
Abstract
Use of powder phage formulations for the treatment of multidrug resistant pulmonary infections is gaining attention. To achieve therapeutic benefits, it is critical for phages to remain stable in the formulation. Assessment of phage stability relies on plaque assay (bioactivity), which requires powder samples to be reconstituted in liquid. The purpose of this study was to develop an innovative approach using photothermal-induced resonance enhanced atomic force microscopy infrared spectroscopy (AFM-IR) to assess the presence of phages and investigate their protein conformation in solid state. Staphylococcal phage S83 was spray dried with lactose and sodium stearate using spray drying. The phage powder recrystallized at 60% relative humidity (RH), so it was stored and handled below this RH. For the AFM-IR measurements spray dried Staphylococcal phage Sa83 powder was embedded in resin, followed by microtome sectioning. AFM-IR spectra collected from different regions within the microtomed sections revealed the presence of phage proteins with amide I and amide II bands at 1640 cm-1 and 1550 cm-1, respectively. The phages were confirmed to be stable as the plaque assay showed negligible titer reduction after spray drying. Our results thus demonstrated the utility of AFM-IR for characterization of nano-sized phages present in extremely low quantity in spray dried particles. These biologically active phages were shown to retain their physical and chemical integrity in the spray dried particles.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R33AI121627)
This publication has 34 references indexed in Scilit:
- Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infectionsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Chemical Imaging Beyond the Diffraction Limit: Experimental Validation of the PTIR TechniqueSmall, 2012
- Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapyJournal of Pharmacy and Pharmacology, 2011
- Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureusPLOS ONE, 2011
- In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosisJournal of Applied Microbiology, 2010
- Application of Fourier Transform Infrared Spectroscopy and Chemometrics for Differentiation of Salmonella enterica Serovar Enteritidis Phage TypesApplied and Environmental Microbiology, 2010
- Raman Spectroscopy and Related Techniques in BiomedicineSensors, 2010
- Pseudomonas aeruginosabiofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategiesExpert Opinion on Therapeutic Targets, 2010
- Chemical mapping of the distribution of viruses into infected bacteria with a photothermal methodUltramicroscopy, 2008
- Physical Characterization of Component Particles Included in Dry Powder Inhalers. I. Strategy Review and Static CharacteristicsJournal of Pharmaceutical Sciences, 2007